Yusuf ATALAY, Ahmet Huseyin ACAR, Fatih ASUTAY

The investigation of effects of proton pump inhibitors (PPI) using on maxillary bone mineral density

Aim: Proton pump inhibitors (PPI) have been widely used throughout the world. The effects of the PPIs on bone mineral density (BMD) is important for oral surgeons. The aim of this study was evaluate alterations in bone mineral density in patients using PPI.Material and Methods: A total of 92 patients were enrolled in the study and were separated into 4 groups (24 in control group, 22 in Lansoprazole group, 24 in Pantoprazole group and 22 in Esomeprazole group). Hounsfield Unit scores were measuredseparately of the incisor, canine, premolar, molar and tubule regions in the jaws with computed tomography. The measurement area in the dental regions was defined as an area of 2mm2 at least 2mm from the apex of the teeth. All data were collected and statistically analysed.Results: There was no significant difference between the groups in respect of mean age. There were no significant differences between the control and the study groups. Also no significant difference was found among the study groups.Conclusion: These data revealed that there were no correlations between decreased maxillary bone mineral density and proton pump inhibitor use. Further studies with more extensive samples should take into consideration drug doses and the period of use.

PDF

___

Özden, A. Proton Pompa İnhibitörleri ve Kullanım Güvenirliği. Güncel Gastroenteroloji Dergisi 2013;17:179-204.
Graziani, G, Como G, Badalamenti S, et al. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrol Dial, Transplant 1995;10:1376-80.
O’Connell, MB, Madden, DM, Murray, AM, et al. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J MEd 2005;118:778-81.
Histing T, Anton C, Scheuer C, et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. J Surgical Res 2012;173:83-90.
Histing T, Stenger D, Scheuer C. Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. Calcif Tissue Int 2012;90:507-14.
Pytlik M, Cegiela U, Folwarczna J, et al. Proton pump (H+/K+-ATPase) inhibitors weaken the protective effect of alendronate on bone mechanical properties in estrogen-deficient rats. Pharmacol Rep 2012;64:625-34.
Wilson, C. Proton-pump inhibitors and fractures. Nature reviews Endocrinology 2012;8:625.
Fraser LA, Leslie WD, Targownik LE, The effect of proton pump inhibitors on fracture risk: report from the canadian multicenter osteoporosis study. osteoporosis study Osteoporos Int 2013;24:1161-8.
Asutay F, Atalay Y, Acar AH, et al. Mandibular bone mineral density in patients with Behçet’s disease.Therapeutical Clin Risk Management 2015;11:1587-91.
Atalay Y, Çakmak Ö, Asutay F, et al. Decreased mandibular bone mineral density in adults with familial mediterranean fever. Acta Medica Mediterranea 2016;32:255.
Ozan O, Orhan K, Turkyilmaz I. Correlation between bone density and angular deviation of implants placed using CT-generated surgical guides. J Craniofacial surg 2011;22:1755-61.
Turkyilmaz I, Aksoy U, McGlumphy EA. Two alternative surgical techniques for enhancing primary implant stability in the posterior maxilla: a clinical study including bone density, insertion torque, and resonance frequency analysis data. Clin Implant Dent Relat Res 2008;10:231-7
Turkyilmaz I, McGlumphy EA. Influence of bone density on implant stability parameters and implant success: a retrospective clinical study. BMC Oral Health 2008;8:32.
Gray SL, LaCroix AZ, Larson J, Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women’s Health Initiative. Arc Intern Med 2010;170:765-71.
Targownik LE, Lix LM, Metge CJ, et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008;179:319-26.
Yang YX, Lewis JD, Epstein S, Long-term proton pump inhibitor therapy and risk of hip fracture. Jama 2006;296:2947-53.
Freedberg DE, Haynes K, Denburg MR, et al. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporosis 2015;26:2501-7.
Esfahanizadeh N, Davaie S, Rokn AR, et al. Correlation between bone mineral density of jaws and skeletal sites in an Iranian population using dual X-ray energy absorptiometry. Dent Res J. (Isfahan) 2013;10:460-6.
Pommer B, Hof M, Fadler A,et al. Primary implant stability in the atrophic sinus floor of human cadaver maxillae: impact of residual ridge height, bone density, and implant diameter. Clin Oral Implants Res 2014;25:e109-13.
Al Subaie A, Emami E, Tamimi I, Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae. J Clinical Periodontol 2016;43:193-203.
Malizos KN, Papatheodorou LK. The healing potential of the periosteum molecular aspects. Injury 2005;3:S13-9.
Devescovi V, Leonardi E, Ciapett, G, et al. Growth factors in bone repair. Chirurgia Organi Mov 2008;92:161-8.
Giannoudis P, Tzioupis C, Almalki T, et al. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury 2007;38:S90-9.
Yu, EW, Blackwell T, Ensrud KE, et al. Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int 2008;83:251-9.
Ozdil K, Kahraman R, Sahin A, et al. Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int 2013;33:2255-60.
Amoako AO, Jafilan L, Nasiri P, Correlation of bone mineral density scores and proton pump ınhibitors use in the elderly. Curr Rheumatol Rev 2016;12:162-6.
Turkyilmaz I, Tumer C, Ozbek, et al. Relations between the bone density values from computerized tomography, and implant stability parameters: a clinical study of 230 regular platform implants. J Clin Periodontol 2007;34:716-22.
Turkyilmaz I, Tozum TF, Tumer C. Bone density assessments of oral implant sites using computerized tomography. J Oral Rehabil 2007;34:267-72.